Viewpoint: A shot in the arm for generics producers
Domino inksThere is nowhere to hide from the Falsified Medicines Directive. It impacts generics producers in the same way as any other drug manufacturer or re-packager selling into Europe. With just under 48 months to go before the deadline, which is likely to be mid-2018, the clock is ticking for all producers to get their house in order.
The subject was hot on the agenda at the European Generics Association (EGA) meeting in Madrid earlier this month. As generics manufacturers often supply products with much lower margins than patented drug producers, their budgets are restricted when it comes to new investment – which is why many of them have been holding out until the last minute to find the ‘best-fit’ solution for their businesses.
Related Posts
Bsf Jawans Foil Smugglers’ Plans; Seize Phensedyl And Ganja On The Indo-Bangladesh Border
The BSF Jawans have foiled the plans of smugglers and seized Phensedyl and Ganja...
RCMP reveals details of its $92-million plan to erect a 700-kilometre surveillance fence along the Canada-U.S. border
A massive intelligence-gathering network of RCMP video cameras, radar, ground...
Customs agency nails 7 cigarette smugglers
South Korea's customs authorities said Tuesday they have arrested or indicted...
The Rising Threat of Counterfeit Cosmetics In India: Fake Beauty Alert
India’s beauty market has lately experienced an incredible turnaround and holds...